PreSENTIA: Myelodysplastic Syndrome / Leukemia
Myelodysplastic syndrome is a type of blood cancer in which blood cells in the bone marrow do not mature and cannot develop into healthy blood cells. These cells have an abnormal size, shape and phenotype. Myelodysplastic syndrome can lead to the development of acute myeloid leukemia (AML) in which the immature, abnormal cells build up in the bone marrow and the body cannot produce cells such as red blood cells, white blood cells and platelets. People who have inherited Myelodysplastic syndrome have increased risk of developing leukemia in the future, which is the 15th most common type of cancer worldwide.
PreSENTIA hereditary Myelodysplastic syndrome/Leukemia cancer panel tests for numerous germline mutations in 24 genes that could cause blood cancers in the future. Identifying germline mutations associated with cancer susceptibility empowers healthcare providers and patients, as it allows them to take better and more informed decisions.
Created by
Our editorial team consists of medical specialists and scientists in the field of human genetics. All content is created and reviewed in accordance with current scientific standards.
Are you a patient?


Certified laboratories

